BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Bellicum Pharmaceuticals, Inc. 

2 Greenway Plaza
Suite 1380
Houston  Texas  77046  U.S.A.
Phone: 713-798-8670 Fax: 713-798-4950


SEARCH JOBS





Segment
Vaccines





 Company News
Bellicum Pharmaceuticals, Inc. Hauls In $34.4 Million Series B Financing 1/7/2014 6:46:04 AM    More...
Bellicum Pharmaceuticals, Inc. Initiates Clinical Trial With Novel Controlled Dendritic Cell Immunotherapy in Metastatic Castrate Resistant Prostate Cancer 7/9/2013 9:43:52 AM    More...
Bellicum Pharmaceuticals, Inc. Selects DATATRAK International, Inc. (DATA) Solution for Drug Program 9/12/2012 10:46:37 AM    More...
Bellicum Pharmaceuticals, Inc. Appoints Baylor College of Medicine's David M. Spencer as Chief Scientific Officer 4/12/2012 10:28:11 AM    More...
Bellicum Pharmaceuticals, Inc. Closes $20 Million Series B Financing 3/8/2012 7:34:06 AM    More...
Bellicum Pharmaceuticals, Inc. Announces Publication in The New England Journal of Medicine Demonstrating Complete Reversal of Serious Immune Condition in Hematopoietic Stem Cell Transplant Patients 11/3/2011 10:39:35 AM    More...
Bellicum Pharmaceuticals, Inc. Awarded $5.7 Million by the Cancer Prevention and Research Institute of Texas 3/25/2011 6:43:19 AM    More...
Bellicum Pharmaceuticals, Inc. Release: Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine in Phase I/II Study 2/18/2011 6:25:22 AM    More...
Bellicum Pharmaceuticals, Inc. Announces $3 Million in Convertible Note Funding 12/21/2010 7:15:14 AM    More...
Bellicum Pharmaceuticals, Inc. Announces World Renowned Clinical Advisory Board Appointments 11/10/2010 11:20:25 AM    More...
12